| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |